Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Study of IPX066 in Early Parkinson's Disease
2009-010193-38Phase 3Completed
- Sponsor
- Impax Pharmaceuticals
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Parkinson's disease (PD) comparing IPX066 with Placebo (2 arms). Primary endpoint: Change in UPDRS Parts II and III. Started Mar 2009; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-010193-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010193-38.